Abbott Laboratories will spend $25 billion to buy St. Jude Medical Inc. in a cash-stock deal that aims to strengthen the medical device maker's share of the market for cardiovascular care The combined company will offer devices in nearly every area of cardiovascular care, competing directly with industry leaders Medtronic Inc.